i
Sensitivity of Mycobacterium leprae to Telacebec
-
3 2022
-
-
Source: Emerg Infect Dis. 2022; 28(3):749-751
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis| The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials.
-
Subjects:
-
Source:
-
Pubmed ID:35202539
-
Pubmed Central ID:PMC8888226
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: